Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Baijj - demand an extraordinary meeting of shareholders? I think

<Perhaps it is time for many to conclude that PTSC is not such a Shareholder friendly company>

If you are talking about the MMP only, I would agree that the information provided to date has been lacking. But since it is governed by the commercialization agreement, the minimal information can be understood. I'm no fan of the agreement, but it is what it is and that's what we presently have.

But to generalize the lack of MMP info to include everything? Personally, I feel that I have about all the information I need relative to all the other business ventures and dealings. You do not think PTSC has provided sufficient information on these other businesses and dealings? Opty

Share
New Message
Please login to post a reply